Using osteosarcoma cells to decipher the underlying mechanism, we discovered a CNK2-dependent signalling axis, triggered by the RTK AXL, that coordinates the activity of ARF6, RAC1, and RHOA GTPases. The gene discussed is AXL; the disease is osteosarcoma.